The nonthyroidal illness syndrome
The nonthyroidal illness syndrome
批准号:
7537207
负责人:
RONALD Jay KOENIG
金额:
$32.3万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-07-01 至 2012-06-30
关键词:
AccountingAcetylationAcuteAddressAdenovirusesAnimalsCell Culture TechniquesCellsChronic DiseaseDefectDevelopmentEndotoxinsEnzymesEuthyroid Sick SyndromesGene DeletionGenesGenetic TranscriptionHepatocyteHumanHypothalamic DiseasesIodothyronine DeiodinaseKnockout MiceLigandsLigationLipopolysaccharidesMedicalMethylationModelingMusOperative Surgical ProceduresOutcomePhosphorylationPost-Translational Protein ProcessingPuncture procedureRecoveryRoleSepsisSerumSeveritiesSeverity of illnessSyndromeTestingThyroid Hormone ReceptorThyroxineTriiodothyronineTriiodothyronine Receptorsbasecytokineimprovedin vivoiodothyronine deiodinase type Imortalitymouse modelnuclear receptor coactivator 1pituitary thyroid axispreventpromoterresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The nonthyroidal illness syndrome (NTIS), also called the sick euthyroid syndrome, is the state of a low serum thyroid hormone (T3) concentration associated with any acute or chronic illness, without intrinsic disease of the hypothalamic-pituitary-thyroid axis. The severity of the NTIS correlates directly with the severity of illness, and multiple studies show that the severity of the NTIS is an independent and powerful predictor of mortality. The long term objectives of these studies are to understand the mechanisms underlying the NTIS and to address whether it should ever be treated, and if so, what the treatment should be. The first Specific Aim will use cell culture and in vivo mouse models to address the mechanisms underlying the decreased conversion of thyroxine to T3 that characterizes the NTIS. The activity and expression of type 1 iodothyronine deiodinase (D1) are known to be decreased by illness. This effect is due at least in part to a defective ability of thyroid hormone receptors to induce transcription of the D1 gene, Dio1. The relationship between defective D1 expression, the low serum T3, and thyroid hormone receptor coactivator function will be investigated. Specific Aim 2 will use two in vivo mouse models of NTIS, endotoxin administration and sepsis, to test whether a specific therapy (forced expression of a thyroid hormone receptor coactivator) can ameliorate the NTIS and decrease mortality rate. Specific Aim 3 will evaluate the basis for impaired thyroid hormone receptor coactivator function in the NTIS. Cytokine or illness-associated potential mechanisms to be explored include induction of corepressors that compete with the coactivators, redistribution of coactivators to other genes, redistribution of coactivators to other regions of the cell, and abnormalities in post-translational modifications of coactivators. The severity of the nonthyroidal illness syndrome (NTIS) correlates directly with the severity of illness, and multiple studies show that the severity of the NTIS is an independent and powerful predictor of mortality. These studies will address whether treatment of the NTIS improves recovery from serious medical illnesses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
In vivo therapy and mechanisms of PAX8-PPARgamma thyroid cancer
-
批准号:9036341
-
项目类别:
-
资助金额:$49.6万
-
财政年份:2013
-
负责人:RONALD Jay KOENIG
-
依托单位:
In vivo therapy and mechanisms of PAX8-PPARgamma thyroid cancer
-
批准号:8628804
-
项目类别:
-
资助金额:$48.11万
-
财政年份:2013
-
负责人:RONALD Jay KOENIG
-
依托单位:
In vivo therapy and mechanisms of PAX8-PPARgamma thyroid cancer
-
批准号:8451143
-
项目类别:
-
资助金额:$50.43万
-
财政年份:2013
-
负责人:RONALD Jay KOENIG
-
依托单位:
Pax8-PPARgamma regulation of transcription and metabolism in thyroid cancer
-
批准号:8683123
-
项目类别:
-
资助金额:$29.58万
-
财政年份:2010
-
负责人:RONALD Jay KOENIG
-
依托单位:
Pax8-PPARgamma regulation of transcription and metabolism in thyroid cancer
-
批准号:8118802
-
项目类别:
-
资助金额:$31.82万
-
财政年份:2010
-
负责人:RONALD Jay KOENIG
-
依托单位:
Pax8-PPARgamma regulation of transcription and metabolism in thyroid cancer
-
批准号:8504792
-
项目类别:
-
资助金额:$29.4万
-
财政年份:2010
-
负责人:RONALD Jay KOENIG
-
依托单位:
The nonthyroidal illness syndrome
-
批准号:8090377
-
项目类别:
-
资助金额:$31.66万
-
财政年份:2008
-
负责人:RONALD Jay KOENIG
-
依托单位:
The nonthyroidal illness syndrome
-
批准号:7869284
-
项目类别:
-
资助金额:$31.98万
-
财政年份:2008
-
负责人:RONALD Jay KOENIG
-
依托单位:
Michigan Diabetes Research and Training Center
-
批准号:7501664
-
项目类别:
-
资助金额:$20.43万
-
财政年份:2006
-
负责人:RONALD Jay KOENIG
-
依托单位:
Retinoic acid and regulation of BMP4 in development
-
批准号:7082160
-
项目类别:
-
资助金额:$36.65万
-
财政年份:2003
-
负责人:RONALD Jay KOENIG
-
依托单位:
Retinoic acid and regulation of BMP4 in development
-
批准号:6669352
-
项目类别:
-
资助金额:$34.53万
-
财政年份:2003
-
负责人:RONALD Jay KOENIG
-
依托单位:
Retinoic acid and regulation of BMP4 in development
-
批准号:6909055
-
项目类别:
-
资助金额:$36.69万
-
财政年份:2003
-
负责人:RONALD Jay KOENIG
-
依托单位:
Retinoic acid and regulation of BMP4 in development
-
批准号:6755010
-
项目类别:
-
资助金额:$35.53万
-
财政年份:2003
-
负责人:RONALD Jay KOENIG
-
依托单位:
Retinoic acid and regulation of BMP4 in development
-
批准号:7234318
-
项目类别:
-
资助金额:$36.62万
-
财政年份:2003
-
负责人:RONALD Jay KOENIG
-
依托单位:
MICHIGAN NIDDK BIOTECHNOLOGY CENTER
-
批准号:6381937
-
项目类别:
-
资助金额:$52.85万
-
财政年份:2000
-
负责人:RONALD Jay KOENIG
-
依托单位:
MICHIGAN NIDDK BIOTECHNOLOGY CENTER
-
批准号:6524337
-
项目类别:
-
资助金额:$52.85万
-
财政年份:2000
-
负责人:RONALD Jay KOENIG
-
依托单位:
CORE--CELL AND MOLECULAR BIOLOGY FACILITY
-
批准号:6417657
-
项目类别:
-
资助金额:$19.33万
-
财政年份:2000
-
负责人:RONALD Jay KOENIG
-
依托单位:
MICHIGAN NIDDK BIOTECHNOLOGY CENTER
-
批准号:6231326
-
项目类别:
-
资助金额:$53.0万
-
财政年份:2000
-
负责人:RONALD Jay KOENIG
-
依托单位:
CORE--CELL AND MOLECULAR BIOLOGY FACILITY
-
批准号:6357038
-
项目类别:
-
资助金额:$19.33万
-
财政年份:1999
-
负责人:RONALD Jay KOENIG
-
依托单位:
CORE--CELL AND MOLECULAR BIOLOGY FACILITY
-
批准号:6301018
-
项目类别:
-
资助金额:$16.48万
-
财政年份:1999
-
负责人:RONALD Jay KOENIG
-
依托单位:
海外基金